Naundorf M, Scholz H, Matthes G, Schweiger F
Klinik für Chirurgie Bereichs Medizin (Charité) der Humboldt-Universität zu Berlin.
Beitr Orthop Traumatol. 1990 Sep;37(9):489-92.
With the submitted study of 165 HVV-vessel-transplantations the marking properties like reduced immunogenity, primary athrombogenicity, form fixated vascular lumen, ability for punction, flow reduction and stability for storage were possible to prove. Few complications (thromboses, aneurysms, infections) and also low rate of revision marks the long-term progress of this bioprosthesis. It will be stated with emphasis, that the use of this vascular device is indicated, if the patient's veins for creation of an arteriovenous vascular access is not available. In long-term progress the rate of function is better in comparison with other similar or synthetic materials for prostheses.
通过对165例人脐静脉血管移植的研究,可以证明其具有降低免疫原性、原发性抗血栓形成性、固定形态的血管腔、穿刺能力、血流减少和储存稳定性等标记特性。很少有并发症(血栓形成、动脉瘤、感染),且翻修率也很低,这标志着这种生物假体的长期进展。需要着重指出的是,如果患者没有可用的静脉来建立动静脉血管通路,则表明可以使用这种血管装置。从长期来看,与其他类似或合成的假体材料相比,其功能率更好。